<DOC>
	<DOCNO>NCT02984046</DOCNO>
	<brief_summary>Acute bronchiolitis common viral infection infant mainly due RSV rhinovirus . Biomarkers useful predict severity . The serum CC16 marker epithelial aggression . Its rate increase RSV bronchiolitis infant less 7 month . It could early predictive biomarker severity acute bronchiolitis , secondarily development asthma . Two marker airway aggression seem increase acute bronchiolitis : serum SP-D protein serum soluble receptor sRAGE .</brief_summary>
	<brief_title>Acute Bronchiolitis Severity Markers : Interest Protein CC16</brief_title>
	<detailed_description>Prospective , monocentric , case-control study Primary end-point : correlation serum CC16 level severity bronchiolitis , evaluate clinical scoring system establish time admission Paediatric Emergency Unit . Secondary end-points : correlation urinary CC16 ; correlation risk factor bronchial epithelial aggression , virus , immediate morbidity mortality . Study serum SP-D sRAGE level .</detailed_description>
	<mesh_term>Bronchiolitis</mesh_term>
	<criteria>Infants 1 year old hospitalize acute bronchiolitis Broncho dysplasia Preterm 34 week Cystic fibrosis Immune deficiency Suspicion primary ciliary dyskinesia Congenital heart disease Acute renal failure</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Year</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Acute bronchiolitis</keyword>
	<keyword>RSV</keyword>
	<keyword>CC16</keyword>
	<keyword>SP-D</keyword>
	<keyword>sRAGE</keyword>
	<keyword>Severity</keyword>
	<keyword>Biomarkers</keyword>
</DOC>